News
Global Cannabis News & Analysis | Business of Cannabis
News · page 17
- CBD Market
US Hemp Industry in Limbo as FDA Deadline for Cannabinoid Definitions Arrives
The Food and Drug Administration’s (FDA) 90-day deadline to clarify which cannabinoids will be banned under the incoming, controversial intoxicating hemp ban falls today.
- Investment & Finance
French Excellence at the Heart of a High-Capacity EU-GMP Site
PGP Farmer closes a €3m funding round to become a leading player in EU-GMP medical cannabis production in Europe French biotech company PGP Farmer unveils the closing of a €3 million funding round with private investors.
- Prescribers & Clinics
Collapsed Cannim Sees Liquidators Target $32m in Voidable Transactions as UK Creditors Face Enforcement Gap
Collapsed international cannabis operator Cannim has officially been placed into liquidation following a failed sales process, seeing its myriad of creditors vie for their share of the tens of millions of dollars now reportedly outstanding.
- Medical Cannabis
Medical Cannabis Police Guidance Published, But No Training Programme Planned
Medical cannabis once again found itself at the centre of the UK mainstream media’s attention this week, following a troubling coroner’s finding that a prescription ‘contributed to’ a patient’s death.
- International Regulation
Germany’s Cannabis Future: Political Posturing vs. Market Reality
Last month (January 15, 2026) Germany’s Bundesrag held a debate on the hotly contested amendments aimed at significantly restricting medical cannabis prescriptions, and potentially transforming the industry.
- Industry Trends
Insurance Has Become a Critical Benchmark for Cannabis Industry Maturity
Since the emergence of the legal cannabis industry across the Western world, operators have persistently been forced to deal with an issue faced by few counterparts in established sectors: they can’t get insured.
- Clinical Research
Latest Studies Map Cannabis Efficacy Across Pain, Migraine, and Autism Applications
Welcome to Business of Cannabis’ new research digest, unpacking the latest clinical evidence shaping cannabis therapeutics.
- International Regulation
France’s Budget Chaos Nears Resolution, Removing Major Barrier for Medical Cannabis Rollout
Earlier this week (Tuesday, January 27), France’s government survived two no-confidence votes, finally passing its contentious 2026 budget following months of political crisis that had largely paralysed non-urgent policymaking.
- Medical Cannabis
Is Europe Moving Away From Cannabis Flower? – Why Companies Are Betting on CE-Certified Devices
Last week, we reported on an emerging trend in the European medical cannabis industry, which is seeing regulators in incoming markets favour alternative modes of administration, challenging the ubiquity of dried flower.
- Start-Ups
New Platform Aims to Become ‘Trustpilot for Medical Cannabis’ with Verified Patient Reviews
As incoming European markets look towards alternative delivery mechanisms like oils and vaporisers, more mature markets like the UK remain dominated by traditional dried cannabis flower, representing around 80% of all prescriptions.
- Medical Cannabis
UK’s First Medical Cannabis Legal Helpline Launches as Patients Navigate New Police Guidance
UK medical cannabis clinic Releaf has launched a new 24/7 on-demand legal support service for its prescribed patients, helping navigate common issues with their medication with professional guidance.
- International Regulation
Is Europe Moving Away From Cannabis Flower?
Spain’s medicines agency has published the first official guidance for medical cannabis preparations, confirming that its incoming market will exclude raw cannabis flower in favour of ‘standardised’ oral solutions prepared exclusively in hospital pharmacies.
